Results 91 to 100 of about 5,617,166 (283)

Trends in condensed matter physics: is research going faster and faster?

, 2012
In this paper we study research trends in condensed matter physics. Trends are analyzed by means of the the number of publications in the different sub-fields as function of the years.
Attaccalite, C., Barland, S.
core   +1 more source

Wastewater Treatment by Advanced Oxidation Process and Their Worldwide Research Trends [PDF]

, 2019
Background: Water is a scarce resource and is considered a fundamental pillar of sustainable development. The modern development of society requires more and more drinking water. For this cleaner wastewater, treatments are key factors.
Agüera López, Ana María, Esteban García, Ana Belén, Garrido Cárdenas, José Antonio, Manzano Agugliaro, Francisco, Sánchez Pérez, José Antonio   +4 more
core   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Cellular and molecular associations with intrinsic brain organization

Nature Communications
Understanding how cellular and molecular architecture underpins the large-scale organization of human brain function is a central challenge in neuroscience.
Guozheng Feng, Jiayu Chen, Jing Sui, Vince D. Calhoun   +3 more
doaj   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Recent Advances in Graph Partitioning

, 2015
We survey recent trends in practical algorithms for balanced graph partitioning together with applications and future research ...
A Buluç, A Felner, A George, A Lisser, A Pothen, A Trifunović, AB Kahng, AE Feldmann, AH Land, AJ Soper, B Brandfass, B Hendrickson, B Hendrickson, B Hendrickson, B Junker, B Monien, B Peng, BW Kernighan, C Aykanat, C Chevalier, C Chevalier, C Farhat, C Lanczos, C Walshaw, C Walshaw, C Walshaw, C Walshaw, C Walshaw, C Walshaw, CE Bichot, CE Ferreira, D Delling, D Delling, D Delling, D Drake, D Luxen, D Ron, D Ron, D Wagner, DA Papa, DE Drake Vinkemeier, E Jeannot, E Rolland, F Comellas, F Glover, F Glover, F Pellegrini, F Pellegrini, F Pellegrini, F Schulz, FT Leighton, G Even, G Karypis, G Karypis, G Karypis, G Zumbusch, H Li, H Meyerhenke, H Meyerhenke, H Meyerhenke, H Meyerhenke, H Meyerhenke, HD Simon, HD Simon, I Moulitsas, I Safro, I Safro, J Chen, J Cong, J Fietz, J Hromkovič, J Hungershöfer, J Maue, J Maue, J Shalf, JR Gilbert, K Andreev, K Lang, K Schloegel, K Schloegel, K Schloegel, KS Camilus, L Brunetta, L Grady, L Lovász, LA Sanchis, LR Ford, M Armbruster, M Bader, M Birn, M Fiedler, M Jerrum, M Newman, M Sellmann, M Zhou, MR Garey, N Sensen, O Goldschmidt, P Chardaire, P Galinier, P Korosec, P Sanders, P Sanders, R Diekmann, R Diekmann, R Glantz, R Preis, RD Williams, S Arora, S Huang, S Lafon, S Lloyd, S Pettie, SE Karisch, SY Chan, T Bui, T Kieritz, U Benlic, U Benlic, U Feige, V Osipov, WE Donath, WE Donath, WW Hager, WW Hager, X Sui, Y Low, YM Kim, Ü Çatalyürek   +128 more
core   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Linking brain entropy to molecular and cellular architecture in psychosis

NeuroImage
Brain entropy reflects the complexity of intrinsic activity and has been linked to both cognitive function and psychiatric disorders. Yet its connection to the brain’s neurochemical and cellular architecture remains poorly understood.
Qiang Li, Jingyu Liu, Vince D. Calhoun
doaj   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source